Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics

Astellas

Status

Completed

Conditions

Kidney Transplantation

Treatments

Other: Chart Review

Study type

Observational

Funder types

Industry

Identifiers

NCT00902980

FKC-010

Details and patient eligibility

About

This is a multicentre, observational, non-interventional, retrospective analysis by chart review.

Full description

This study will compare differences in patient and graft related outcomes in renal transplant recipients followed in regional transplant centers versus satellite clinics.

Enrollment

264 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

Patient is at least 18 months post transplant
Patient had the current transplant during the period 1 July 1997 to no less than 18 months prior to chart review
Patient is currently on tacrolimus/MMF or AZA - or cyclosporine/MMF or AZA based immunosuppressive therapy
Patient is not a recipient of dual kidney or multi -organ transplant
Patient has a functioning graft (i.e. patient does not require dialysis)
Patient is recipient of a renal transplant including living or cadaveric, related or non-related, or pediatric en bloc kidneys, but excluding kidney-pancreas transplant recipients
Patient received the current transplant at one of six identified regional transplant centers
Patient is currently followed in a regional or satellite community based nephrology clinic